Super Panel - A Changing Clinical Landscape: The Future is Now

Kick-off your virtual DIA experience with a unique opportunity to engage with 20 of the industry's most influential thought leaders who will give voice to the shifts that are impacting the clinical ecosystem now and their predictions on what the future holds.

This dynamic two-hour virtual panel gives you the opportunity to interact with the expert panel, provide your opinions on the factors that are currently impacting clinical operations, and share your predictions for what’s ahead.


  • Percival Barretto-Ko, President, Astellas Pharma

  • Bonnie A Brescia, Founding Principal, Corporate Development Officer, BBK Worldwide

  • James Corrigan, President & CEO, ERT

  • Donald A. Deieso, Ph.D., Executive Chairman and Chief Executive Officer, WCG

  • Ken Getz, Deputy Director, Tufts

  • Robert Goldman, Ph.D., Head, Global Clinical Research & Medical Affairs, Sunovion

  • John Hubbard, Ph.D., CEO, Signant Health

  • Suresh Katta, Founder and CEO, Saama Technologies

  • Patrick Lindsay, CEO, UBC

  • Craig Lipset, Former Head of Clinical Innovation at Pfizer

  • Michelle Longmire, CEO, Medable

  • Jamie Macdonald, CEO, Parexel

  • Alistair Macdonald, CEO, Syneos Health

  • Steve Rosenberg, SVP and General Manager Health Science Global Business Unit, Oracle

  • Julie Ross, President, Advanced Clinical

  • Craig Serra, Global Head, Strategy and Innovation, Data Operations, Novartis

  • Nagaraja Srivatsan, Senior VP and Chief Digital Officer, Research and Development Solutions, IQVIA

  • Rebecca Vermeulen, Vice President Patient and Society Strategy Lead, Product Development, Roche at Genentech

  • Mark Wildgust, Ph.D., Vice President, Global Medical Affairs, Oncology, Janssen Pharmaceutical Companies of Johnson & Johnson

FREE access

© 2020 by

  • Black Facebook Icon
  • Black LinkedIn Icon